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ABSTRACT
Objective: To verify the disposal of pharmaceutical waste performed in pediatric units. 
Method: A descriptive and observational study conducted in a university hospital. The 
convenience sample consisted of pharmaceuticals discarded during the study period. 
Handling and disposal during preparation and administration were observed. Data 
collection took place at pre-established times and was performed using a pre-validated 
instrument. Results: 356 drugs disposals were identified (35.1% in the clinic, 31.8% in 
the intensive care unit, 23.8% in the surgical unit and 9.3% in the infectious diseases 
unit). The most discarded pharmacological classes were: 22.7% antimicrobials, 14.8% 
electrolytes, 14.6% analgesics/pain killers, 9.5% diuretics and 6.7% antiulcer agents. The 
most used means for disposal were: sharps’ disposable box with a yellow bag (30.8%), 
sink drain (28.9%), sharps’ box with orange bag (14.3%), and infectious waste/bin with a 
white bag (10.1%). No disposal was identified after drug administration. Conclusion: A 
discussion of measures that can contribute to reducing (healthcare) waste volume with 
the intention of engaging reflective team performance and proper disposal is necessary.
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INTRODUCTION
The ecological issue has been widely discussed by society 
in recent decades, aiming at concepts such as environmental 
preservation, improving quality of life and sustainability. 
According to the Instituto Brasileiro de Geografia e Estatística 
(Brazilian Institute of Geography and Statistics – IBGE) in 
its National Survey of Basic Sanitation (Pesquisa Nacional 
de Saneamento Básico – PNSB, 2008), 259,547 tons of waste 
are collected daily, of which 8,909 are waste generated by 
health services. Among the 4,469 municipalities studied, 
41.5% did not have any type of treatment for such waste(1).
Healthcare Waste (HCW) (RSS in Brazil – Resíduos de 
Serviços de Saúde) is any material that poses a risk to public 
health due to the presence of biological materials that are 
capable of causing infections; hazardous chemicals; sharps 
and radioactive waste materials(2-3). HCW is classified into 
five groups according to their characteristics, according to 
the Resolutions of the National Environmental Council 
(Conselho Nacional do Meio Ambiente – CONAMA) num-
ber 358/2005(2) and the Collegiate Board (RDC) of the 
National Sanitary Surveillance Agency (Agência Nacional 
de Vigilância Sanitária – ANVISA) number 306/2004(3). 
According to federal legislation, pharmaceutical waste is 
classified as Group B waste which poses risks to public 
health and to the environment due to its chemical charac-
teristics, including all classes of pharmaceuticals, chemo-
therapeutic drugs, and all others considered dangerous, in 
accordance with the Brazilian Regulatory Standard (Norma 
Brasileira Regulamentadora – NBR) 10004 of the Brazilian 
Association of Technical Standards (Associação Brasileira de 
Normas Técnicas – ABNT)(2-3).
In the State of São Paulo, the Sanitary Surveillance 
Center ordinance (CVS-21)(4) regulates techniques on the 
management of Pharmaceutical Hazardous Waste (RPM in 
Brazil – Resíduos Perigosos de Medicamentos), classifying it as 
chemical waste that presents a risk to human health and the 
environment. They are separated into two types according to 
the quantity and concentration of pharmaceuticals, namely 
RPM type 1 and RPM type 2.
Within the hospital setting, pediatric units can be high-
lighted as waste producers, including vaccines and drug 
residues that exceed therapeutic demand or that are past 
their expiration date. Due to a lack of products available 
which are compatible with pediatric patients, professionals 
are obliged to manipulate the drugs in an attempt to achieve 
the required dosage, often discarding surplus product(5). In 
conjunction with pharmaceutical disposal, there is a lack 
of preparation on behalf of professionals in relation to the 
different types of waste and the correct way to dispose of it. 
Studies carried out seeking to identify nursing team knowl-
edge about HCW report that the nurses declared having 
some knowledge about the subject and that they consider the 
nurses’ participation in managing this waste fundamentally 
important(6-10).
Thus, the present study aimed to verify pharmaceutical 
waste disposal by professionals in pediatric units of a uni-
versity hospital in the city of São Paulo.
METHOD
A descriptive and observational study conducted in four 
pediatric units of a university hospital in São Paulo (clinical, 
surgical, infectious diseases and intensive care (ICU) units).
The physical structure of the units as well as the contain-
ers available for the pharmaceutical waste disposal in these 
sectors were observed prior to data collection.
The sample consisted of pharmaceuticals discarded dur-
ing the study period, characterizing a convenience sample. 
Saline and glycoside solutions were excluded from the study 
since their physicochemical characteristics pose no danger 
to the environment or to human health(2-3).
Data collection was performed by two undergraduate 
nursing students who observed the pharmaceutical waste 
disposal performed by the professionals working in the 
studied units.
A pre-test of the data collection instrument was per-
formed. After necessary adjustments, the instrument used 
included variables related to the study site (clinical, surgi-
cal, infectious disease and ICU units); Medication or solu-
tion (name of the pharmaceutical); presentation form of 
the drug (liquid, oil, powder/lyophilized powder, cream, 
dragée/sugar-coated tablet, gel, paste, pill/tablet, capsule, 
others); Type of primary packaging (plastic ampoule, glass 
ampoule, tube, plastic vial, vial ampoule, blister, plastic bag, 
others); Place of disposal after preparation or after admin-
istration, with variables referring to the disposal site (room, 
isolation, corridor, nursing station, utility room, procedure 
room, not applicable); Volume of discarded drug; disposed 
in its commercially available form or in solution; and dis-
posal means (regular bin with black bag, recyclable waste/
bin with transparent bag, infectious waste/bin with white 
bag, hazardous chemicals waste/bin, sharps disposable box 
with yellow bag, sharps hazardous chemicals disposable box 
with orange bag, sluice sinks and slop hoppers, the medicine 
room sink drain, the patient’s bedroom sink drain, watertight 
containers, others).
Data were collected in the morning and evening from 
March to May 2012. Fourteen (14) collection periods were 
performed at each unit of the study at two time intervals, 
occurring from 8 to 10 am and 2 to 4 pm.
Collected data were organized in Excel® spreadsheets 
and after analysis they were presented in tables and figures 
according to absolute and relative frequency.
Data collection was only carried out after the approval 
of the Research Ethics Committee of the Institution under 
Opinion number 5563/12, with authorization from the 
Teaching and Research Coordinator of the Hospital Nursing 
Board, as well as authorization from the nurses in charge of 
the respective units.
The observed professionals were clarified regarding 
the research objective, data collection strategies and were 
guaranteed anonymity and confidentiality for the data 
obtained through the observations. The participants were 
then invited to participate in the study, and after agree-
ment they were asked to sign the Clear and Informed 
Consent Form.
924 Rev Esc Enferm USP · 2016;50(6):922-928 www.ee.usp.br/reeusp
Evaluating pharmaceutical waste disposal in pediatric units
RESULTS
Twenty-eight (28) data collection periods were per-
formed in each studied unit, totaling 112 moments in 224 
hours of observation, identifying 356 pharmaceutical dis-
posals in the four units, of which 125 (35.1%) occurred in 
the clinical unit, 113 (31.8 %) in the ICU, 85 (23.8%) in the 
surgical unit and 33 (9.3%) in the infectious diseases unit.
The results concerning the most disposed pharmacologi-
cal classes are presented in Table 1.
The category ‘Others’ was comprised of the following 
pharmacological classes: immunosuppressive, hepatoprotec-
tive, antacids, antianginal, antiepileptic, systemic antifungal, 
h1 antihistamines, vitamins, anticoagulants, antiemetics, 
hypnotics, phosphodiesterase inhibitors and laxatives.
Regarding the commercially available physical form of 
all the study pharmaceuticals, it is possible to verify that 
188 (52.8%) were liquids, 111 (31.2%) were tablets and 57 
(16.0%) were powder/lyophilized powder. It is worth noting 
that no drug disposal was observed in the forms of paste, oil, 
cream, dragée/sugar-coated tablet, gel or capsule during the 
data collection period.
Figure 1 shows the main types of primary packag-
ing identified. Drug disposal with tube packaging was 
not observed.
Table 1 – Pharmacological class of the pharmaceuticals disposed of, according to the hospital unit – São Paulo, SP, Brazil, 2012.
Pharmacological
Class
Type of unit Total
Surgical unit
(n = 85)
Clinical
(n = 125)
ICU
(n = 113)
Infectious Diseases
(n = 33) (n = 356)
f (%) f (%) f (%) f (%) f (%)
Antimicrobial 32 37.6 18 14.4 22 19.5 9 27.3 81 22.8
Electrolyte, Thinner 5 5.9 19 15.2 22 19.5 7 21.2 53 14.9
Painkiller 18 21.2 14 11.2 14 12.4 6 18.2 52 14.6
Diuretic – – 22 17.6 10 8.8 2 6.1 34 9.5
Antiulcer 10 11.8 5 4 9 8 – – 24 6.7
Anticonvulsant 6 7.1 6 4.8 7 6.2 1 3 20 5.6
Anti-inflammatory 5 5.9 2 1.6 6 5.3 4 12.1 17 4.8
Anti-hypertensive 1 1.2 13 10.4 2 1.8 – – 16 4.5
Anti-anemic 3 3.5 8 6.4 – – – – 11 3.1
Muscle Relaxant – – 8 6.4 – – – – 8 2.2
Anxiolytic 3 3.5 1 0.8 3 2.6 – – 7 2
Antidepressant – – – – 6 5.3 – – 6 1.7
Others 2 2.3 9 7.2 12 10.6 4 12.1 27 7.6
Legend: ICU – Intensive Care Unit.
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Figure 1 – Primary packaging type of disposed drugs – São Paulo, SP, Brazil, 2012.
Regarding the physical form of the drug when it was dis-
posed, 51.7% was disposed in its original physical form and 
the remaining (48.3%) in solution after handling/manipula-
tion. Regarding the place of drug disposal, it was possible to 
observe that the entire amount (100.0%) was discarded at 
the place of preparation and always after handling/manipu-
lation. No disposal was found after drug administration.
Results regarding the means used for disposal after 
preparation are presented in Table 2. This is followed by 
Figure 2, in which samples were classified into hazardous or 
non-hazardous substances according to the disposal means, 
in accordance with the RDC resolution number 306/2004(3) 
and CONAMA number 358/2005(2).
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DISCUSSION
In the present investigation, pharmaceutical disposal in 
four different pediatric hospitalization units was verified. The 
number of beds, type of care provided to the patients, char-
acteristics of drug therapy and the complexity of the children 
differed from one unit to another, therefore waste disposal 
generation was different among the units. According to the 
CONAMA Resolution number 358/2005(2), the instant 
when the waste is generated is the mandatory moment to 
perform its correct separation in relation to its characteris-
tics, in order to reduce the disposal volume and in order to 
guarantee health and environment protection, in addition 
to promoting cost reduction(3). About 70% to 80% of the 
amount of waste generated in health services that are not 
considered hazardous waste can become potentially con-
taminating when this step is not performed correctly(11).
According to current legislation, pharmaceutical waste 
belongs to group B – Chemicals(2-3,12). Of the variables 
belonging to this group, pharmaceuticals that pose a risk 
to health or the environment when not submitted to the 
‘3R’s’ process (reduce, reuse or recycle) must be disposed of 
according to their hazard characteristics, and forwarded for 
treatment in specific landfills for hazardous waste (Class I), 
or if they do not present any characteristic which poses a 
degree of danger, they can be sent to licensed landfills(2-3).
Chemical waste in a liquid state must be subjected to 
specific treatment in accordance with the contaminating 
substance, and final disposal in landfills is prohibited. If the 
waste does not present hazardous characteristics, it can be 
released into the sewage network, provided that the guide-
lines established by the competent environmental agencies, 
water managers and sanitation are obeyed(2). Thus, there is 
a need for information about which substances are allowed, 
since doubts can lead to errors in separating these materi-
als, leading to disposing substances that pose a risk to the 
population and the environment(13).
In all available legislation on healthcare waste, there are 
gaps in the disposal of pharmaceuticals used in hospital 
institutions, making it difficult for managers and even pro-
fessionals who are in direct care.
In evaluating the pharmaceuticals analyzed in the pres-
ent study in relation to the means chosen for disposal, we 
observed non-compliance with the recommendations backed 
by legislation(2-4). There is a lack of proper disposal sites 
for these drugs, with no availability of proper containers 
with identification of the associated risk symbols suitable 
for each type of substance according to its physicochemi-
cal characteristics(4).
According to CVS 21/08(4), a considerable quantity of the 
waste, including hazardous waste is inadequately disposed, 
leading to environmental contamination and resulting in risks 
Table 2 – Disposal means of pharmaceutical/medication, according to the hospitalization unit – São Paulo, BB, Brazil, 2012.
Disposal means
Type of Unit Total
ICU
(n = 113)
Surgical
(n = 85)
Infectious Diseases
(n = 33)
Clinical
(n = 125) (n = 356)
f (%) f (%) f (%) f (%) f (%)
Sharps disposable box with YB 37 32.8 15 17.7 23 69.7 35 28 110 30.9
Sink drain 39 34.5 4 4.7 2 6.1 58 46.4 103 28.9
Sharps box with OB – – 51 60 – – – – 51 14.3
Infectious waste/bin with WB 4 3.5 2 2.3 8 24.2 22 17.6 36 10.1
Recyclable waste/bin with TB 33 29.2 – – – – – – 33 9.2
Hazardous chemicals waste/bin with OB – – 13 15.3 – – – – 13 3.6
Regular bin with BB – – – – – – 7 5.6 7 2
Regular bin with TB – – – – – – 3 2.4 3 1
Legend: ICU – Intensive Care Unit; YB (yellow bag); OB (orange bag); WB (white bag); TB (transparent bag); BB (black bag).
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Figure 2 – Environmental hazard classification according to disposal means – São Paulo, SP, Brazil, 2012.
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to the population. This resolution emphasizes that a mixture 
of pharmaceutical waste with infectious waste is considered 
to be serious, since these are sent to treatment by incineration 
which can lead to a release of toxic gases and vapors, thereby 
not contributing to reducing their chemical risk(4). Still, 36 
disposals were performed by this means, with 30.5% being 
composed of substances classified as hazardous(2-3).
Regarding all drugs disposed of in the sharps dispos-
able boxes with a yellow bag, 36.3% presented a risk to the 
environment and to human health(2-3). Availability of such 
boxes at the drug preparation sites was common in all the 
units observed and where pharmaceutical disposal occurred, 
especially those packaged in glass ampoules as primary pack-
aging. Sharps disposable boxes belong to group E in waste 
classification, and its destination is similar to infectious waste 
since the institution advises the box must be closed and 
wrapped in a white bag suitable for infectious waste after 
reaching 2/3 capacity(14), with mixture occurring between 
these wastes being considered incorrect(2-3).
In relation to pharmaceuticals disposed of in the sharps 
box with orange bag only available in the Surgical unit, 
80.3% of the drugs were considered hazardous(2-3). The 
orange bag in this means is a process adaptation for this 
material proposed by the studied institution. Considering 
the total number of pharmaceuticals disposed in hazardous 
chemicals waste/bins with an orange bag, 53.8% consisted 
of drugs that needed special care in handling.
Orange bags are destined for hazardous chemical waste 
disposal in solid form, being the best means for disposing of 
this type of waste(4). The orange bag was also available in the 
hazardous-chemical bin, and only available in the surgical unit.
We should also highlight pharmaceutical disposal down 
the sink drain. Approximately 46% of the pharmaceuticals 
disposed of in this way presented a risk factor, requiring a 
specific means; among them was tacrolimus, an immunosup-
pressant class classified as RPM type I(4). In relation to the 
rest of the pharmaceuticals disposed of down the sink drain, 
there is no consideration in the current legislation that indi-
cates danger to the environment, and no contraindication 
of this means for final disposal provided there is a sewage 
treatment network to treat this effluent(2). Studies point to 
the presence of several drugs in surface water, which are not 
removed by sewage treatment plants (STPs)(15-22).
The presence of drugs in common waste, although in less 
quantity than other means, also needs attention. This waste 
is sent to landfills where they can come into contact with 
the population working at these sites, as well as contaminate 
the soil(11).
The recyclable waste bin with a transparent bag is 
intended for disposing of waste that can be recycled, such 
as paper, cardboard, and secondary packaging of medicines, 
provided that they have not been in contact with them(11). 
The use of this means for disposing of drugs is not recom-
mended(23). Even so, this means was used for this purpose in 
36.1% of pharmaceuticals that offered risk to the population 
and the environment. All these disposals occurred in the ICU.
A study conducted to diagnose healthcare waste man-
agement in Rio Grande do Sul found that those belonging 
to Group B had not undergone the necessary care during 
their disposal, as only 57% of the studied hospitals promoted 
separation/sorting of this waste. The main reason mentioned 
in the study was insufficient employee knowledge in the 
establishments about environmental aspects and associated 
possible risks, justifying the importance of health team train-
ing and orientation(23).
In addition to the changes that are necessary, there must 
also be awareness, “(…) a political will by those who are 
managing services to enforce health standards and recom-
mendations, helping those who are already aware of the 
importance of adopting this behavior and promoting under-
standing in those who still do not know”(24).
CONCLUSION
The results allowed for verifying that the characteristics 
of drug therapy and the complexity of the children differed 
from one place to the other, consequently directly reflecting 
waste disposal production.
Regarding the drug disposal site, the most frequently 
adopted was the sharps disposable box with a yellow garbage 
bag, however a relevant finding was identifying that 28.9% 
of the disposals were performed via sink drain, demonstrat-
ing an important factor regarding the environmental impact 
of healthcare waste, as 48.2% of the total primary sample 
corresponded to medicines that pose a risk to human health 
and the environment.
In all the national legislations available on healthcare 
waste, there are gaps in means of pharmaceutical disposal 
used in hospital institutions, making it difficult for managers 
and even those in direct care.
It is necessary to discuss measures that contribute to 
reducing pharmaceutical disposal volume, such as instituting 
individualized dosing and health team training relating to 
managing healthcare waste, with the intention to engage in 
reflexive action on waste generation and its adequate dis-
posal and with a consequent impact on nursing practice and 
environmental health.
RESUMO
Objetivo: Verificar o descarte dos resíduos de medicamentos realizado em unidades pediátricas. Método: Estudo descritivo e 
observacional, realizado em um hospital universitário. A amostra de conveniência foi constituída pelos medicamentos descartados 
durante o período de estudo. Observaram-se a manipulação e o descarte durante o preparo e a administração. A coleta dos dados 
ocorreu em horários preestabelecidos e realizada por meio de instrumento pré-validado. Resultados: Identificaram-se 356 descartes 
de medicamentos (35,1% na clínica, 31,8% na unidade de cuidados intensivos, 23,8% na cirúrgica e 9,3% na infectologia). As classes 
farmacológicas mais descartadas foram: 22,7% antimicrobianos, 14,8% eletrólitos, 14,6% analgésicos, 9,5% diuréticos e 6,7% antiulcerosos. 
Vias mais utilizadas: caixa descartável para perfurocortante com saco amarelo (30,8%), ralo da pia (28,9%), caixa de perfurocortante 
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com saco laranja (14,3%) e lixeira infectante com saco branco (10,1%). Não foi identificado descarte após a administração dos fármacos. 
Conclusão: Faz-se necessária a discussão de medidas que contribuam para a redução do volume de resíduos, com o intuito de engajar a 
atuação reflexiva da equipe e o descarte adequado.
DESCRITORES
Resíduos de Serviços de Saúde; Preparações Farmacêuticas; Enfermagem Pediátrica.
RESUMEN
Objetivo: Verificar el descarte de los resíduos de fármacos realizado en unidades pediátricas. Método: Estudio descriptivo y observacional, 
realizado en un hospital universitario. La muestra de conveniencia estuvo constituida de los fármacos descartados durante el período 
de estudio. Se observaron la manipulación y el descarte durante la preparación y la administración. La recolección de datos ocurrió en 
horarios prestablecidos y fue llevada a cabo mediante instrumento pre validado. Resultados: Se identificaron 356 descartes de fármacos 
(el 35,1% en la clínica, el 31,8% en la unidad de cuidados intensivos, el 23,8% en la quirúrgica y el 9,3% en la infectología). Las clases 
farmacológicas más descartadas fueron: el 22,7% de antimicrobianos, el 14,8% de electrolitos, el 14,6% de analgésicos, el 9,5% de 
diuréticos y el 6,7% de antiulcerosos. Medios más utilizados: caja desechable para punzocortante con bolsa amarilla (30,8%), rebosadero 
del lavabo (28,9%), caja de punzocortante con bolsa naranja (14,3%) y basurero infectante con bolsa blanca (10,1%). No se identificó 
descarte tras la administración de los medicamentos. Conclusión: Se hace necesaria la discusión de medidas que contribuyan a la 
reducción del volumen de resíduos a fin de involucrar la actuación reflexiva del equipo y el descarte adecuado.
DESCRIPTORES
Residuos Sanitarios; Preparaciones Farmacéuticas; Enfermería Pediátrica.
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